UK biotech groups merge into ‘supercluster’ powerhouse

Two regional biotech networks in the UK have agreed to join forces and create the continent's leading supercluster of drug developers. Cambridge-based ERBI and the London Biotechnology Network have agreed to merge into one organization representing more than 750 life sciences companies that span from start-ups to Pfizer and Genzyme. And the group will include three of the world's top academic research centers, Cambridge, Imperial College and UCL. All together, the new organization will...